Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia.

Enomoto T, Tatara A, Goda M, Nishizato Y, Nishigori K, Kitamura A, Kamada M, Taga S, Hashimoto T, Ikeda K, Fujii Y.

J Pharmacol Exp Ther. 2019 Dec;371(3):692-702. doi: 10.1124/jpet.119.260869. Epub 2019 Oct 2.

PMID:
31578257
2.

A novel Tungsten-based fiducial marker for multi-modal brain imaging.

Ose T, Autio JA, Ohno M, Nishigori K, Tanki N, Igesaka A, Mori T, Doi H, Wada Y, Nakajima I, Watabe H, Hayashi T.

J Neurosci Methods. 2019 Jul 15;323:22-31. doi: 10.1016/j.jneumeth.2019.04.014. Epub 2019 May 10.

3.

Comparison of 125I- and 111In-labeled peptide probes for in vivo detection of oxidized low-density lipoprotein in atherosclerotic plaques.

Temma T, Kondo N, Yoda K, Nishigori K, Onoe S, Shiomi M, Ono M, Saji H.

Ann Nucl Med. 2018 Jul;32(6):425-429. doi: 10.1007/s12149-018-1255-y. Epub 2018 Apr 12.

PMID:
29651757
4.

Radiofluorinated probe for PET imaging of fatty acid binding protein 4 in cancer.

Temma T, Nishigori K, Onoe S, Sampei S, Kimura I, Ono M, Saji H.

Nucl Med Biol. 2015 Feb;42(2):184-91. doi: 10.1016/j.nucmedbio.2014.10.006. Epub 2014 Oct 16.

PMID:
25457456
5.

Development of a radioiodinated triazolopyrimidine probe for nuclear medical imaging of fatty acid binding protein 4.

Nishigori K, Temma T, Onoe S, Sampei S, Kimura I, Ono M, Saji H.

PLoS One. 2014 Apr 14;9(4):e94668. doi: 10.1371/journal.pone.0094668. eCollection 2014.

6.

Radioiodinated peptide probe for selective detection of oxidized low density lipoprotein in atherosclerotic plaques.

Nishigori K, Temma T, Yoda K, Onoe S, Kondo N, Shiomi M, Ono M, Saji H.

Nucl Med Biol. 2013 Jan;40(1):97-103. doi: 10.1016/j.nucmedbio.2012.08.002. Epub 2012 Nov 15.

PMID:
23157986
7.

Tissue factor detection for selectively discriminating unstable plaques in an atherosclerotic rabbit model.

Temma T, Ogawa Y, Kuge Y, Ishino S, Takai N, Nishigori K, Shiomi M, Ono M, Saji H.

J Nucl Med. 2010 Dec;51(12):1979-86. doi: 10.2967/jnumed.110.081216. Epub 2010 Nov 15.

8.

Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques.

Kuge Y, Takai N, Ogawa Y, Temma T, Zhao Y, Nishigori K, Ishino S, Kamihashi J, Kiyono Y, Shiomi M, Saji H.

Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2093-104. doi: 10.1007/s00259-010-1521-2. Epub 2010 Jul 13.

PMID:
20625725
9.

Vesiculo-bullous dermatomyositis: report of three cases.

Nishigori K, Yamamoto T, Yokozeki H.

Dermatol Online J. 2009 Apr 15;15(4):6.

10.

Toxic shock syndrome with extensive epidermal necrosis in a 9-year-old girl.

Nishigori K, Igawa K, Sasaki K, Sawada Y.

J Eur Acad Dermatol Venereol. 2006 Nov;20(10):1334-5. No abstract available.

PMID:
17062059
11.

Human bones of the burial mounds in matsuyama. Report I.

Fujimori K, Chikamori K, Matsubara H, Miyai M, Nishigori K, Araki T, Yamamoto A, Yamashita S, Shinomiya T, Yamada M.

Tokushima J Exp Med. 1981 Jun;28(1-2):21-6. No abstract available.

PMID:
7027535

Supplemental Content

Loading ...
Support Center